China Shineway Pharmaceutical Group Limited (OTCMKTS:CSWYY – Get Free Report) was the recipient of a large decrease in short interest in the month of September. As of September 30th, there was short interest totaling 155 shares, a decrease of 47.5% from the September 15th total of 295 shares. Based on an average daily volume of 388 shares, the days-to-cover ratio is currently 0.4 days.
China Shineway Pharmaceutical Group Stock Performance
OTCMKTS:CSWYY opened at C$21.49 on Wednesday. The stock’s 50 day moving average price is C$19.83 and its 200 day moving average price is C$19.26. China Shineway Pharmaceutical Group has a 52-week low of C$18.16 and a 52-week high of C$22.23.
China Shineway Pharmaceutical Group Company Profile
China Shineway Pharmaceutical Group Ltd. is a Chinese pharmaceutical company focused on the development, manufacture and sale of traditional Chinese medicines and related healthcare products. Its portfolio includes prescription and over-the-counter medicines in forms such as injections, capsules, tablets, oral liquids and granules.
The company’s products address a range of therapeutic areas, including respiratory, cardiovascular, digestive and gynecological conditions. Its better-known traditional Chinese medicine products include Qingkailing and Shuanghuanglian formulations, which are marketed in multiple dosage forms.
China Shineway is headquartered in Shijiazhuang, Hebei Province, China, and primarily serves the Chinese pharmaceutical market through hospitals, pharmacies and other healthcare distribution channels.
Featured Articles
- Five stocks we like better than China Shineway Pharmaceutical Group
- A Chinese Rival Just Spooked Memory Stocks—How Worried Should Micron Investors Be?
- Could T-Mobile’s Satellite Competition Fears Create a Buying Opportunity?
- Surgical Precision, Sustainable Returns: Johnson & Johnson Secures Its Cash Flow Runway
- Tesla’s Robotaxi Lands in Paris—But Europe’s Real Fight Is Over Cheap EVs
Receive News & Ratings for China Shineway Pharmaceutical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China Shineway Pharmaceutical Group and related companies with MarketBeat.com's FREE daily email newsletter.
